MARKET

BLRX

BLRX

BioLine RX
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.500
+0.030
+1.21%
Pre Market: 2.620 +0.12 +4.80% 08:00 11/13 EST
OPEN
2.420
PREV CLOSE
2.470
HIGH
2.550
LOW
2.340
VOLUME
63.04K
TURNOVER
--
52 WEEK HIGH
13.05
52 WEEK LOW
2.320
MARKET CAP
24.50M
P/E (TTM)
-0.0576
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BLRX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

BLRX News

  • BioLineRx Ltd. (BLRX) CEO Phil Serlin on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.1d ago
  • BioLineRx up 2% premarket on Q3 results
  • Seeking Alpha - Article.1d ago
  • BioLine Rx Q3 EPS $(0.03) Beats $(0.64) Estimate
  • Benzinga.2d ago
  • BioLineRx Reports Third Quarter 2019 Financial Results and Provides Corporate Update
  • PR Newswire.2d ago

More

Industry

Biotechnology & Medical Research
+0.28%
Pharmaceuticals & Medical Research
+0.27%

Hot Stocks

Name
Price
%Change

About BLRX

BioLine RX Ltd is an Israel-based company engaged in the development of therapeutics, from preclinical-stage development to advanced clinical trials, for a range of medical needs. Its clinical therapeutic candidates under development consist of BL-1020 that is in Phase II/III clinical trials to improve cognitive function in schizophrenia patients; BL-1040, which is under pivotal CE-Mark registration trial for the prevention of cardiac remodeling following an acute myocardial infarction; BL-5010, which has completed Phase I/II clinical trials for non-surgical removal of skin lesions; BL-1021 that has completed Phase Ia clinical trial for the treatment of neuropathic pain or pain that results from damage to nerve fibers, and BL-7040, a synthetic oligonucleotide, which is in Phase II clinical trial for the treatment of inflammatory bowel disease. The Company also has 11 pre-clinical stage development products for various indications.
More

Webull offers BioLineRX Ltd. (BLRX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.